FI955667L - Adjuvantteja RS-viruksen vastaisia rokotteita varten - Google Patents

Adjuvantteja RS-viruksen vastaisia rokotteita varten Download PDF

Info

Publication number
FI955667L
FI955667L FI955667A FI955667A FI955667L FI 955667 L FI955667 L FI 955667L FI 955667 A FI955667 A FI 955667A FI 955667 A FI955667 A FI 955667A FI 955667 L FI955667 L FI 955667L
Authority
FI
Finland
Prior art keywords
adjuvants
rsv vaccines
rsv
vaccines
Prior art date
Application number
FI955667A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI955667A7 (fi
FI955667A0 (fi
Inventor
Gerald E Hancock
Dan J Speelman
Patrick J Frenchick
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22078872&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI955667(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FI955667A0 publication Critical patent/FI955667A0/fi
Publication of FI955667A7 publication Critical patent/FI955667A7/fi
Publication of FI955667L publication Critical patent/FI955667L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI955667A 1993-05-25 1994-05-24 Adjuvantteja RS-viruksen vastaisia rokotteita varten FI955667L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6785593A 1993-05-25 1993-05-25
PCT/US1994/005833 WO1994027636A1 (en) 1993-05-25 1994-05-24 Adjuvants for vaccines against respiratory syncytial virus

Publications (3)

Publication Number Publication Date
FI955667A0 FI955667A0 (fi) 1995-11-24
FI955667A7 FI955667A7 (fi) 1996-01-12
FI955667L true FI955667L (fi) 1996-01-12

Family

ID=22078872

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955667A FI955667L (fi) 1993-05-25 1994-05-24 Adjuvantteja RS-viruksen vastaisia rokotteita varten

Country Status (15)

Country Link
US (1) US5723130A (de)
EP (1) EP0705109B2 (de)
JP (1) JP3734263B2 (de)
AT (1) ATE196737T1 (de)
AU (1) AU676340B2 (de)
CA (1) CA2163550A1 (de)
DE (1) DE69426077T3 (de)
DK (1) DK0705109T4 (de)
ES (1) ES2150493T5 (de)
FI (1) FI955667L (de)
GR (1) GR3034785T3 (de)
NO (1) NO954786L (de)
PT (1) PT705109E (de)
RU (1) RU2160119C2 (de)
WO (1) WO1994027636A1 (de)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
US6727230B1 (en) 1994-03-25 2004-04-27 Coley Pharmaceutical Group, Inc. Immune stimulation by phosphorothioate oligonucleotide analogs
PT784486E (pt) * 1994-10-05 2006-07-31 Univ Vanderbilt Inerleucina-12 como um adjuvante para vacinas contra paramyxoviridae
US6488934B1 (en) * 1995-02-25 2002-12-03 Smithkline Beecham Biologicals S.A. Hepatitis B vaccine
UA56132C2 (uk) * 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
US6975708B1 (en) * 1996-04-17 2005-12-13 Convergys Cmg Utah, Inc. Call processing system with call screening
US5867562A (en) * 1996-04-17 1999-02-02 Scherer; Gordon F. Call processing system with call screening
US6180398B1 (en) * 1996-07-12 2001-01-30 Virogeneitics Corporation Two-step immunization procedure against the pyramyxoviridae family of viruses using recombinant virus and subunit protein preparation
US20020136739A1 (en) * 1996-07-12 2002-09-26 Cates George A. Subunit respiratory syncytial virus preparation
DE69720024D1 (de) * 1996-07-12 2003-04-24 Aventis Pasteur Immunisierungsverfahren in zwei schritten gegen pyramyxoviridae-viren unter verwendung abgeschwächter viraler stämme und preparation von proteinuntereinheiten
US6020182A (en) * 1996-07-12 2000-02-01 Connaught Laboratories Limited Subunit respiratory syncytial virus vaccine preparation
US6406705B1 (en) * 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
GB9706957D0 (en) 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
US6699478B1 (en) * 1997-09-19 2004-03-02 Wyeth Holdings Corporation Enhanced immune response to attachment (G) protein of Respiratory Syncytial Virus
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
US7790856B2 (en) * 1998-04-07 2010-09-07 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize beta amyloid peptide
US20080050367A1 (en) * 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
US6787523B1 (en) * 1997-12-02 2004-09-07 Neuralab Limited Prevention and treatment of amyloidogenic disease
TWI239847B (en) * 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US20050059802A1 (en) * 1998-04-07 2005-03-17 Neuralab Ltd Prevention and treatment of amyloidogenic disease
HK1039072A1 (zh) * 1998-05-07 2002-04-12 科里克萨有限公司 佐剂组合物及其使用方法
GB9820525D0 (en) 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
DE69935606T9 (de) * 1998-10-16 2021-03-11 Glaxosmithkline Biologicals S.A. Adjuvanzsysteme und impfstoffe
US7198920B1 (en) 1999-01-29 2007-04-03 Corika Corporation HER-2/neu fusion proteins
GB9909077D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Biolog Novel compositions
JP2002540168A (ja) * 1999-03-26 2002-11-26 ウォルター リード アーミー インスティテュート オブ リサーチ 多価デングウイルスワクチン
US6537557B1 (en) * 1999-03-26 2003-03-25 The United States Of America As Represented By The Secretary Of The Army Attenuated dengue-4 virus vaccine
US6511667B1 (en) * 1999-03-26 2003-01-28 The United States Of America As Represented By The Secretary Of The Army Attenuated dengue-2 virus vaccine
ID30407A (id) * 1999-05-13 2001-11-29 American Cyanamid Co Formulasi-formulasi kombinasi bahan penambah
GB0000891D0 (en) * 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
KR20080027973A (ko) * 2000-06-22 2008-03-28 와이어쓰 홀딩스 코포레이션 보조제 배합물로서의 큐에스-21 및 아이엘-12
US7229623B1 (en) * 2000-08-03 2007-06-12 Corixa Corporation Her-2/neu fusion proteins
HUP0600589A2 (en) * 2000-11-10 2006-11-28 Wyeth Corp Adjuvant combination formulations
US7700751B2 (en) 2000-12-06 2010-04-20 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize β-amyloid peptide
RU2208786C1 (ru) * 2001-12-28 2003-07-20 Государственное образовательное учреждение высшего профессионального образования Санкт-Петербургская государственная педиатрическая медицинская академия Способ определения спонтанной клеточной цитотоксичности
DE10205373B4 (de) * 2002-02-09 2007-07-19 Aloys Wobben Brandschutz
MY139983A (en) * 2002-03-12 2009-11-30 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
MXPA05008156A (es) * 2003-02-01 2005-09-30 Neuralab Ltd Inmunizacion activa para generar anticuerpos para beta-a soluble.
US20060095001A1 (en) * 2004-10-29 2006-05-04 Transcutaneous Technologies Inc. Electrode and iontophoresis device
WO2006066089A1 (en) * 2004-12-15 2006-06-22 Neuralab Limited Humanized amyloid beta antibodies for use in improving cognition
JP2006346368A (ja) * 2005-06-20 2006-12-28 Transcutaneous Technologies Inc イオントフォレーシス装置及びその製造方法
JP2007000342A (ja) * 2005-06-23 2007-01-11 Transcutaneous Technologies Inc 複数薬剤の投与量および投与時期を制御するイオントフォレーシス装置
US8386030B2 (en) * 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US8295922B2 (en) 2005-08-08 2012-10-23 Tti Ellebeau, Inc. Iontophoresis device
US20070088332A1 (en) * 2005-08-22 2007-04-19 Transcutaneous Technologies Inc. Iontophoresis device
WO2007023907A1 (ja) * 2005-08-24 2007-03-01 Transcu Ltd. 冷凍型イオントフォレーシス用電極構造体
JPWO2007026672A1 (ja) * 2005-08-29 2009-03-05 Ｔｔｉ・エルビュー株式会社 イオントフォレーシス用汎用性電解液組成物
JPWO2007029611A1 (ja) * 2005-09-06 2009-03-19 Ｔｔｉ・エルビュー株式会社 イオントフォレーシス装置
US20070112294A1 (en) * 2005-09-14 2007-05-17 Transcutaneous Technologies Inc. Iontophoresis device
EP1925336A4 (de) * 2005-09-15 2011-01-19 Tti Ellebeau Inc Stabartiges iontophoresegerät
KR20080056200A (ko) * 2005-09-16 2008-06-20 티티아이 엘뷰 가부시키가이샤 카테터형 이온토포레시스 장치
US20090299264A1 (en) * 2005-09-28 2009-12-03 Tti Ellebeau, Inc. Electrode Assembly for Dry Type Iontophoresis
JP2009509677A (ja) * 2005-09-30 2009-03-12 Ｔｔｉ・エルビュー株式会社 小胞封入活性物質のイオントフォレーシス送達
US20070083186A1 (en) * 2005-09-30 2007-04-12 Darrick Carter Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles
WO2007041115A1 (en) * 2005-09-30 2007-04-12 Tti Ellebeau Inc. Method and system to detect malfunctions in an iontophoresis device that delivers active agents to biological interfaces
WO2007037476A1 (ja) * 2005-09-30 2007-04-05 Tti Ellebeau, Inc. 睡眠導入剤と興奮剤の投与量および投与時期を制御するイオントフォレーシス装置
US20070078376A1 (en) * 2005-09-30 2007-04-05 Smith Gregory A Functionalized microneedles transdermal drug delivery systems, devices, and methods
KR20080066712A (ko) * 2005-09-30 2008-07-16 티티아이 엘뷰 가부시키가이샤 관능화된 미세바늘 경피 약물 전달 시스템, 장치 및 방법
CA2622777A1 (en) * 2005-09-30 2007-04-12 Tti Ellebeau, Inc. Iontophoresis device to deliver multiple active agents to biological interfaces
US20090299265A1 (en) * 2005-09-30 2009-12-03 Tti Ellebeau, Inc. Electrode Assembly for Iontophoresis Having Shape-Memory Separator and Iontophoresis Device Using the Same
US20070135754A1 (en) * 2005-09-30 2007-06-14 Hidero Akiyama Electrode assembly for iontophoresis for administering active agent enclosed in nanoparticle and iontophoresis device using the same
US20070197955A1 (en) * 2005-10-12 2007-08-23 Transcutaneous Technologies Inc. Mucous membrane adhesion-type iontophoresis device
WO2007079116A1 (en) * 2005-12-28 2007-07-12 Tti Ellebeau, Inc. Electroosmotic pump apparatus and method to deliver active agents to biological interfaces
WO2007079190A2 (en) * 2005-12-29 2007-07-12 Tti Ellebeau, Inc. Device and method for enhancing immune response by electrical stimulation
US8784810B2 (en) * 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
JP2010502293A (ja) * 2006-09-05 2010-01-28 Ｔｔｉ・エルビュー株式会社 誘導型電源を用いる経皮薬物送達システム、装置及び方法
US8062783B2 (en) 2006-12-01 2011-11-22 Tti Ellebeau, Inc. Systems, devices, and methods for powering and/or controlling devices, for instance transdermal delivery devices
US20080292625A1 (en) * 2007-04-18 2008-11-27 Sally Schroeter Prevention and treatment of cerebral amyloid angiopathy
US8003097B2 (en) * 2007-04-18 2011-08-23 Janssen Alzheimer Immunotherapy Treatment of cerebral amyloid angiopathy
EP1997830A1 (de) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV-spezifische Bindemoleküle und Mittel zu ihrer Herstellung
PT2182983E (pt) * 2007-07-27 2014-09-01 Janssen Alzheimer Immunotherap Tratamento de doenças amiloidogénicas com anticorpos anti-abeta humanizados
JO3076B1 (ar) * 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
BRPI0819210A2 (pt) * 2007-10-25 2015-06-23 Trellis Bioscience Inc Anticorpos de proteína g anti-rsv
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies
TW201121604A (en) * 2009-06-09 2011-07-01 Tti Ellebeau Inc Long life high capacity electrode, device, and method of manufacture
US9433671B2 (en) 2012-03-30 2016-09-06 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
US8883717B2 (en) 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods
JP6886406B2 (ja) * 2015-04-16 2021-06-16 ザ リサーチ ファウンデイション フォー ザ ステイト ユニバーシティー オブ ニューヨーク コバルトポルフィリン・リン脂質コンジュゲート及びポリヒスチジンタグを含むナノ構造体
WO2017048689A1 (en) 2015-09-16 2017-03-23 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
US11043823B2 (en) * 2017-04-06 2021-06-22 Tesla, Inc. System and method for facilitating conditioning and testing of rechargeable battery cells
US12343390B2 (en) 2018-08-07 2025-07-01 Wisconsin Alumni Research Foundation (Warf) Recombinant biologically contained filovirus vaccine
WO2020163804A1 (en) 2019-02-08 2020-08-13 Wisconsin Alumni Research Foundation (Warf) Humanized cell line
US11807872B2 (en) 2019-08-27 2023-11-07 Wisconsin Alumni Research Foundation (Warf) Recombinant influenza viruses with stabilized HA for replication in eggs
WO2021150874A1 (en) 2020-01-24 2021-07-29 Wisconsin Alumni Research Foundation (Warf) Recombinant influenza viruses with stabilized na
US12290562B2 (en) 2020-03-25 2025-05-06 Wisconsin Alumni Research Foundation (Warf) Recombinant multivalent influenza viruses
WO2022152939A1 (en) 2021-01-18 2022-07-21 Conserv Bioscience Limited Coronavirus immunogenic compositions, methods and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1188985A (en) † 1980-07-01 1985-06-18 National Research Development Corporation Production of viral antigens
US5057540A (en) * 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
KR0137963B1 (ko) * 1987-12-23 1998-04-30 로버트 에이. 아미테이지 인간의 호흡기 합포체성 바이러스에 대한 당단백질 면역 단편을 함유하는 키메라(chimeric) 당단백질
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
GB9120221D0 (en) † 1991-09-23 1991-11-06 Smithkline Beecham Biolog Novel compounds
RU2026345C1 (ru) * 1991-11-26 1995-01-09 Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии им.Пастера Штамм ротавируса человека для получения диагностических и профилактических сывороток
RU2031945C1 (ru) * 1992-09-08 1995-03-27 Петр Петрович Федченко Способ инактивации вируса спида
ATE157882T1 (de) * 1993-03-23 1997-09-15 Smithkline Beecham Biolog 3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen

Also Published As

Publication number Publication date
EP0705109B1 (de) 2000-10-04
CA2163550A1 (en) 1994-12-08
FI955667A7 (fi) 1996-01-12
EP0705109B2 (de) 2004-01-02
NO954786D0 (no) 1995-11-24
AU6957194A (en) 1994-12-20
NO954786L (no) 1996-01-23
DK0705109T4 (da) 2004-05-10
ATE196737T1 (de) 2000-10-15
US5723130A (en) 1998-03-03
ES2150493T5 (es) 2004-07-01
DE69426077T3 (de) 2004-09-02
WO1994027636A1 (en) 1994-12-08
JPH08510749A (ja) 1996-11-12
PT705109E (pt) 2001-02-28
DK0705109T3 (da) 2000-11-13
AU676340B2 (en) 1997-03-06
ES2150493T3 (es) 2000-12-01
EP0705109A4 (de) 1998-09-02
EP0705109A1 (de) 1996-04-10
FI955667A0 (fi) 1995-11-24
GR3034785T3 (en) 2001-02-28
RU2160119C2 (ru) 2000-12-10
DE69426077D1 (de) 2000-11-09
DE69426077T2 (de) 2001-05-10
JP3734263B2 (ja) 2006-01-11

Similar Documents

Publication Publication Date Title
FI955667L (fi) Adjuvantteja RS-viruksen vastaisia rokotteita varten
DE69126606D1 (de) Vakzine
DK0671948T3 (da) Vaccinepræparat indeholdende adjuvanser
FI943171L (fi) Ureaasipohjainen rokote Helicobacter-infektiota vastaan
FI930580L (fi) Tri- och tetravalensiska monopecifika antigen bindande proteiner
CY2007016I2 (el) Εμβολιο ιου θηλωματος
DE69227382D1 (de) Angetriebener Trokar
NO930699D0 (no) Hoeyeffektiv vaeske/vaeske hydrosyklon
FI921311L (fi) Matrisdisplay med stereoskopiskt system
AT399966B (de) Synchronisiervorrichtung
FI944052A7 (fi) Oraalinen rokote
FI924305L (fi) N-alkyl-3-fenyl-3-(2-alkyltiofenoxi)propylaminer
NO922728D0 (no) Vaksine mot coccidiose
EP0967993A4 (de) Anti-kokaine vakzine
ITMI920391A1 (it) Dispositivo per aspirapolvere-battitappeto
FI925295L (fi) Baenksystem foer kompositioner avsedda foer jordbruk
FI925032L (fi) Vaccinsammansaettningar
FI933210A7 (fi) Vesikauhunvastainen avirulentti rokote
FI934710A0 (fi) 4-aryl-3-(heteroarylureido)kinolinderivat
DK56591D0 (da) Toerringsfremgangsmaade
FI934599L (fi) Tryckutrymme
FI931015A0 (fi) 2-(2-substituerade pyrrolidinyltio)karbapenemderivat
FI925218A0 (fi) Distansbaoge foer isolerfoerglasningar
KR930005071U (ko) 흡입기(Sucker)
KR930006280U (ko) 완력기